Indication
Diabetic nephropathy
Diabetic nephropathy is a progressive microvascular complication of diabetes mellitus affecting the renal system, recognized as a leading cause of chronic kidney disease and end-stage renal disease worldwide. Read more about Diabetic nephropathy
90 drugs 63 manufacturers
Drugs that treat it
Common Diabetic nephropathy therapies.
CAPTOPRIL
IRBESARTAN
IRBESARTAN
LOSARTAN POTASSIUM
LOSARTAN POTASSIUM
IRBESARTAN
IRBESARTAN
CAPTOPRIL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiabetic nephropathy is a progressive microvascular complication of diabetes mellitus affecting the renal system, recognized as a leading cause of chronic kidney disease and end-stage renal disease worldwide.
Pathophysiologically, chronic hyperglycemia and altered glomerular hemodynamics trigger mesangial expansion, thickening of the glomerular basement membrane, nodular glomerulosclerosis, and podocyte loss.
Clinically, it typically manifests with glomerular hyperfiltration in its earliest stages, progressing to persistent albuminuria, worsening hypertension, and a gradual decline in estimated glomerular filtration rate.
- nih.gov
Diabetic nephropathy is a progressive microvascular complication of diabetes mellitus affecting the renal system, recognized as a leading cause of chronic kidney disease and end-stage renal disease worldwide Pathophysiologically, chronic hyperglycemia and altered glomerular hemodynamics trigger mesangial expansion, thickening of the glomerular basement membrane, nodular glomerulosclerosis, and podocyte loss
- nih.gov
Diabetic nephropathy is a progressive microvascular complication of diabetes mellitus affecting the renal system, recognized as a leading cause of chronic kidney disease and end-stage renal disease worldwide Clinically, it typically manifests with glomerular hyperfiltration in its earliest stages, progressing to persistent albuminuria, worsening hypertension, and a gradual decline in estimated glomerular filtration rate
- nih.gov
Pathophysiologically, chronic hyperglycemia and altered glomerular hemodynamics trigger mesangial expansion, thickening of the glomerular basement membrane, nodular glomerulosclerosis, and podocyte loss
- nih.gov
Clinically, it typically manifests with glomerular hyperfiltration in its earliest stages, progressing to persistent albuminuria, worsening hypertension, and a gradual decline in estimated glomerular filtration rate
Personalize your experience
Follow Diabetic nephropathy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.